Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000903

Drug Information
Synonyms17beta-hydroxyestr-4-en-3-one; LMST02010044; 46476_FLUKA; Estr-4-en-3-one, 17beta-hydroxy-; MolPort-003-849-312; Norandrostenolon; nandrolone; D08250; MLS002222325; ZINC03814379; (8R,9S,10R,13S,14S,17S)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one; Nortestosteronum; Menidrabol; C18H26O2; Estr-4-en-3-one, 17-hydroxy-, (17-beta)- (9CI); LT03330030; Oestrenolon; HMS2051I04; AC1L1U32; CHEMBL757; EINECS 207-101-0; 434-22-0; 17-Hydroxy-Estr-4-Ene-3-One; Nandrolon; 17beta-Hydroxy-19-norandrost-4-en-3-one; 74640_ALDRICH; Nandrolonum [INN-Latin]; 4-Estren-17beta-ol-3-one; Nandrolona; Nadrolone; Nortestonate; 17beta-Hydroxy-19-nor-4-androsten-3-one; SMR000058610; 19-Nortestosterone; SAM001246751; Estr-4-en-3-one, 17-beta-hydroxy-; Estr-4-en-3-one, 17-hydroxy-, (17-beta)-; CHEBI:7466; Estr-4-en-3-one, 17-hydroxy-, (17beta)-; 19-Norandrostenolone; LS-64851; (17-beta)-17-Hydroxyestr-4-en-3-one; decadura (TN); Nandrolona [INN-Spanish]; Estr-4-en-3-one, 17beta-hydroxy- (8CI); 17-beta-Hydroestr-4-en-3-one; Norandrostenolone; HSDB 3368; Nortestosterone; UNII-6PG9VR430D; Estr-4-en-3-one, 17-hydroxy-, (17beta)- (9CI); 46476_RIEDEL; Nandrolonum; AC-15207; decadura; N7252_SIGMA; 17beta-Hydroxy-4-estren-3-one; 74640_FLUKA; C07254; (17beta)-17-hydroxyestr-4-en-3-one; NSC 3351; CPD000058610; Estrenolone; CID9904; (17beta)-17-hydroxyestr-4-en-3-one; 17beta-hydroxy-19-nor-4-androsten-3-one; 17beta-hydroxy-4-estren-3-one; 19-Norandrostenolone; 19-Nortestosterone; 4-estren-17beta-ol-3-one; Nandrolone; NCGC00159416-02; U 2410; Nandrolone (INN)    
Trade NameDurabolin    
IndicationOsteoporosis in post-menopausal womenApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAnabolic Agents    
CAS NumberCAS 434-22-0
PubChem Compound IDCID 9904.    
PubChem Substance IDSID 9463.    
SuperDrug ATC IDA14AB01;    
SuperDrug CAS ID000434220;    
TargetAndrogen receptorAgonist[2]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Expression of androgen receptor on fibroblast and hepatocyte of rats after deep second-degree burn caused by scalding. Sichuan Da Xue Xue Bao Yi Xue Ban. 2005 May;36(3):362-4. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543